Publicaciones (51) Publicaciones de JAVIER VAQUERO RODRÍGUEZ

2024

  1. Enhancing the opportunities for cholangiocarcinoma precision therapy

    Gut

  2. Experimental Model of Biliary Tract Cancers: Subcutaneous Xenograft of Human Cell Lines in Immunodeficient Nude Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 87-98

2023

  1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

  2. Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma

    Liver International, Vol. 43, Núm. 12, pp. 2776-2793

  3. Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1869, Núm. 4

  4. TGFβ-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p

    JHEP Reports, Vol. 5, Núm. 12

2022

  1. A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy

    Cancers, Vol. 14, Núm. 1

  2. Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease

    Cancers, Vol. 14, Núm. 1

  3. Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study

    Antibiotics, Vol. 11, Núm. 10

  4. Evaluation of the definition of hyperdynamic circulation in patients with cirrhosis and ascites

    Hepatology Communications, Vol. 6, Núm. 12, pp. 3528-3538

  5. Genetic alterations shaping tumor response to anti-EGFR therapies

    Drug Resistance Updates, Vol. 64

  6. Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy

    Cell death & disease, Vol. 13, Núm. 2, pp. 143

  7. Improvement of surgical time and functional results after Do-It-Yourself 3D-printed model preoperative planning in acetabular defects Paprosky IIA-IIIB

    Revue de Chirurgie Orthopedique et Traumatologique, Vol. 108, Núm. 6, pp. 741-742

  8. Improvement of surgical time and functional results after do-it-yourself 3D-printed model preoperative planning in acetabular defects Paprosky IIA-IIIB

    Orthopaedics and Traumatology: Surgery and Research, Vol. 108, Núm. 6

  9. Mecanismos del precondicionamiento regenerativo en hepatectomías subtotales en modelo porcino

    Cirugia y cirujanos, Vol. 90, Núm. S1, pp. 61-69

  10. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734

  11. Technique tip: 3D printing surgical guide for pes cavus midfoot osteotomy

    Foot and Ankle Surgery, Vol. 28, Núm. 3, pp. 371-377

  12. Tranexamic Acid in Combination With Vancomycin or Gentamicin Has a Synergistic Effect Against Staphylococci

    Frontiers in Microbiology, Vol. 13

  13. Ultrasound-guided distal minimally invasive metatarsal osteotomies (US-DMMO): A cadaveric study about its safety and accuracy

    Foot and Ankle Surgery, Vol. 28, Núm. 4, pp. 445-449

2021

  1. An Experimental DUAL Model of Advanced Liver Damage

    Hepatology Communications, Vol. 5, Núm. 6, pp. 1051-1068